The Feasibility of an Exercise Intervention in Males at Risk of Oesophageal Adenocarcinoma: a Randomized Controlled Trial

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Feb 24

PMID 25706622

Citations 5

Authors

Brooke M Winzer

Jennifer D Paratz

Jonathan P Whitehead

David C Whiteman

Marina M Reeves

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the feasibility and safety of a 24-week exercise intervention, compared to control, in males with Barrett's oesophagus, and to estimate the effect of the intervention, compared to control, on risk factors associated with oesophageal adenocarcinoma development.

Methods: A randomized controlled trial of an exercise intervention (60 minutes moderate-intensity aerobic and resistance exercise five days/week over 24 weeks; one supervised and four unsupervised sessions) versus attention control (45 minutes stretching five days/week over 24 weeks; one supervised and four unsupervised sessions) in inactive, overweight/obese (25.0-34.9 kg/m2) males with Barrett's oesophagus, aged 18-70 years. Primary outcomes were obesity-associated hormones relevant to oesophageal adenocarcinoma risk (circulating concentrations of leptin, adiponectin, interleukin-6, tumour necrosis factor-alpha, C-reactive protein, and insulin resistance [HOMA]). Secondary outcomes included waist circumference, body composition, fitness, strength and gastro-oesophageal reflux symptoms. Outcomes were measured at baseline and 24-weeks. Intervention effects were analysed using generalised linear models, adjusting for baseline value.

Results: Recruitment was difficult in this population with a total of 33 participants recruited (target sample size: n = 80); 97% retention at 24-weeks. Adherence to the exercise protocol was moderate. No serious adverse events were reported. A statistically significant intervention effect (exercise minus control) was observed for waist circumference (-4.5 [95% CI -7.5, -1.4] cm; p < 0.01). Effects on primary outcomes were not statistically significant.

Conclusion: This small, exploratory trial provides important information to inform future trial development including recruitment rates and estimates of effect sizes on outcomes related to oesophageal adenocarcinoma risk. Future trials should investigate a combined dietary and exercise intervention to achieve greater weight loss in this population and relax inclusion criteria to maximize recruitment.

Trial Registration: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12609000401257.

Citing Articles

Network meta-analysis of the intervention effects of different exercise measures on Sarcopenia in cancer patients.

Liu R, Gao X, Wang L BMC Public Health. 2024; 24(1):1281.

PMID: 38730397 PMC: 11083843. DOI: 10.1186/s12889-024-18493-y.

Changes in Lipoinflammation Markers in People with Obesity after a Concurrent Training Program: A Comparison between Men and Women.

Gonzalez-Jurado J, Suarez-Carmona W, Lopez S, Sanchez-Oliver A Int J Environ Res Public Health. 2020; 17(17).

PMID: 32854366 PMC: 7504010. DOI: 10.3390/ijerph17176168.

Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK Biobank.

Kunzmann A, Mallon K, Hunter R, Cardwell C, McMenamin U, Spence A United European Gastroenterol J. 2018; 6(8):1144-1154.

PMID: 30288276 PMC: 6169059. DOI: 10.1177/2050640618783558.

Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Ulrich C, Himbert C, Holowatyj A, Hursting S Nat Rev Gastroenterol Hepatol. 2018; 15(11):683-698.

PMID: 30158569 PMC: 6500387. DOI: 10.1038/s41575-018-0053-2.

The Effect of Chronic Exercise Training on Leptin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Fedewa M, Hathaway E, Ward-Ritacco C, Williams T, Dobbs W Sports Med. 2018; 48(6):1437-1450.

PMID: 29582381 DOI: 10.1007/s40279-018-0897-1.

References

Thomas K, Koller K, Foster K, Perdue J, Charlesworth L, Chalmers J . The UK clinical research network--has it been a success for dermatology clinical trials?. Trials. 2011; 12:153. PMC: 3126737. DOI: 10.1186/1745-6215-12-153. View

Nelson A, Kokkonen J, Arnall D . Twenty minutes of passive stretching lowers glucose levels in an at-risk population: an experimental study. J Physiother. 2011; 57(3):173-8. DOI: 10.1016/S1836-9553(11)70038-8. View

Byers T, Sedjo R . Does intentional weight loss reduce cancer risk?. Diabetes Obes Metab. 2011; 13(12):1063-72. DOI: 10.1111/j.1463-1326.2011.01464.x. View

Friedenreich C, Neilson H, Woolcott C, Wang Q, Stanczyk F, McTiernan A . Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal women. Cancer Prev Res (Phila). 2011; 5(1):98-108. DOI: 10.1158/1940-6207.CAPR-11-0369. View

Shang J, Wenzel J, Krumm S, Griffith K, Stewart K . Who will drop out and who will drop in: exercise adherence in a randomized clinical trial among patients receiving active cancer treatment. Cancer Nurs. 2012; 35(4):312-22. PMC: 3326216. DOI: 10.1097/NCC.0b013e318236a3b3. View

MacInnis R, English D, Hopper J, Giles G . Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer. 2005; 118(10):2628-31. DOI: 10.1002/ijc.21638. View

OLeary V, Marchetti C, Krishnan R, Stetzer B, Gonzalez F, Kirwan J . Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol (1985). 2005; 100(5):1584-9. PMC: 7037693. DOI: 10.1152/japplphysiol.01336.2005. View

Kubo A, Corley D . Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15(5):872-8. DOI: 10.1158/1055-9965.EPI-05-0860. View

Booth M . Assessment of physical activity: an international perspective. Res Q Exerc Sport. 2000; 71(2 Suppl):S114-20. View

10.

Reseland J, Anderssen S, Solvoll K, Hjermann I, Urdal P, Holme I . Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr. 2001; 73(2):240-5. DOI: 10.1093/ajcn/73.2.240. View

11.

Borst S, de Hoyos D, Garzarella L, Vincent K, Pollock B, Lowenthal D . Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc. 2001; 33(4):648-53. DOI: 10.1097/00005768-200104000-00021. View

12.

Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R . Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002; 290(3):1084-9. DOI: 10.1006/bbrc.2001.6307. View

13.

Black P, Garbutt L . Stress, inflammation and cardiovascular disease. J Psychosom Res. 2002; 52(1):1-23. DOI: 10.1016/s0022-3999(01)00302-6. View

14.

Vizcaino A, Moreno V, Lambert R, Parkin D . Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002; 99(6):860-8. DOI: 10.1002/ijc.10427. View

15.

Polednak A . Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003; 105(1):98-100. DOI: 10.1002/ijc.11029. View

16.

Thrift A, Whiteman D . The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012; 23(12):3155-3162. DOI: 10.1093/annonc/mds181. View

17.

Hickman I, Whitehead J . Structure, signalling and physiologic role of adiponectin-dietary and exercise- related variations. Curr Med Chem. 2012; 19(32):5427-43. DOI: 10.2174/092986712803833155. View

18.

Hur C, Miller M, Kong C, Dowling E, Nattinger K, Dunn M . Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013; 119(6):1149-58. PMC: 3744155. DOI: 10.1002/cncr.27834. View

19.

Duggan C, Onstad L, Hardikar S, Blount P, Reid B, Vaughan T . Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2013; 11(8):934-43. PMC: 3722274. DOI: 10.1016/j.cgh.2013.02.017. View

20.

Fitzgerald R, di Pietro M, Ragunath K, Ang Y, Kang J, Watson P . British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2013; 63(1):7-42. DOI: 10.1136/gutjnl-2013-305372. View